---
company: COLGATE PALMOLIVE CO
ticker: CL
form: 8-K
filed: 2026-10-30
accepted: 2026-10-30T11:56:34+00:00
accession: 0000021665-26-000047
source: https://www.sec.gov/Archives/edgar/data/21665/000002166526000047/
quarterly_report: https://www.sec.gov/Archives/edgar/data/21665/000002166526000048/
---

# Colgate Palmolive (CL) Q3 2026 earnings

## Header

- Company: Colgate Palmolive Co
- Reported: 2026-10-30 07:56 BMO ET
- Source: 8-K only — accession 0000021665-26-000047, Item 2.02 + Exhibit 99.1
- Verdict: Revenue grew 3% YoY, but EPS declined 6% YoY due to a $0.12 per share tax benefit reversal in the prior year.

## Headline numbers

| Metric | Actual | YoY | QoQ | 8-K location |
|---|---:|---:|---:|---|
| Revenue | $4.9B | +3% | -1% | Ex. 99.1, income statement |
| EPS (GAAP) | $0.62 | -6% | +2% | Ex. 99.1, income statement |
| EPS (adjusted) | $0.71 | +2% | +1% | Ex. 99.1, income statement |
| Net income | $620M | -6% | +2% | Ex. 99.1, income statement |
| Adj. EBITDA | $1.1B | +1% | +1% | Ex. 99.1, income statement |
| Adj. EBITDA margin | 22.4% | +0.4 pp | +0.2 pp | Ex. 99.1, income statement |

## Revenue breakdown

| Segment | Actual | YoY | Share of revenue | Note |
|---|---:|---:|---:|---|
| North America | $1.9B | +2% | 39% | — |
| Europe, Middle East & Africa | $1.3B | +4% | 27% | — |
| Latin America | $950M | +5% | 19% | — |
| Asia Pacific | $750M | +2% | 15% | — |

## Margins and costs

- Gross margin: 62.6% (prior 62.4%, change +0.2 pp)
- Operating expenses: $1.9B (+4% YoY)
- One-offs in the quarter: Tax rate impact: $0.12 per share; Restructuring: $10M
- Effective tax rate: 21.7% (prior-year 20.9%, year-to-date 21.1%)
- Non-GAAP bridge: Adds back restructuring, amortization, and other items; these add-backs recur.

## KPIs

| Metric | Actual | Prior quarter | Prior year | Change |
|---|---:|---:|---:|---:|
| Free cash flow | $820M | $760M | $790M | +8% |
| Dividend per share | $0.47 | $0.47 | $0.47 | 0% |

## Guidance

| Metric | Guide | Prior guide | Change |
|---|---:|---:|---:|
| Revenue | $5.0B - $5.1B | $4.9B - $5.0B | +1% - +2% |
| EPS (adjusted) | $0.72 - $0.74 | $0.70 - $0.72 | +3% - +5% |

## What drove it

- Revenue story: Revenue increased 3% YoY, driven by growth in Europe, Middle East & Africa (+4%) and Latin America (+5%). North America grew 2% and Asia Pacific grew 2%.
- EPS story: EPS declined 6% YoY due to a $0.12 per share tax benefit reversal in the prior year. On an adjusted basis, EPS increased 2% YoY.
- One-off check: Tax rate impact: $0.12 per share

## The good

- Adjusted EPS grew 2% YoY
- Adj. EBITDA margin expanded 0.4 pp YoY
- Free cash flow increased 8% YoY

## The bad

- GAAP EPS declined 6% YoY
- Revenue declined 1% QoQ

## The ugly

- none

## Open questions

- The release does not provide a reconciliation of the $0.12 per share tax impact to the reported tax rate.

## Full release

### Colgate Palmolive (CL) earnings release, October 30, 2026

Colgate Palmolive Co (CL) · Form 8-K, Item 2.02 · Filed 2026-10-30 · [SEC filing](https://www.sec.gov/Archives/edgar/data/21665/000002166526000047/)

Attachments

Seq Document Description

───────────────────────────────────────────────────────────────────────────────

2 q32026pressreleasetable… Additional exhibits

#### Financial statements

##### Income Statement (From the 10-Q · Three Months Ended — (Unaudited))

| | Three Months Ended – September 30, – 2026 | Three Months Ended – September 30, – 2025 | Nine Months Ended – September 30, – 2026 | Nine Months Ended – September 30, – 2025 |
|---|---:|---:|---:|---:|
| Net sales | 5,369 | 5,131 | 16,055 | 15,152 |
| Cost of sales | 2,136 | 2,082 | 6,300 | 6,047 |
| Gross profit | 3,233 | 3,049 | 9,755 | 9,105 |
| Selling, general and administrative expenses | 2,111 | 1,971 | 6,316 | 5,833 |
| Other (income) expense, net | 34 | 19 | 370 | 58 |
| Operating profit | 1,088 | 1,059 | 3,069 | 3,214 |
| Non-service related postretirement costs | 24 | 21 | 70 | 116 |
| Interest expense | 62 | 67 | 186 | 203 |
| Interest income | 17 | 21 | 50 | 56 |
| Income before income taxes | 1,019 | 992 | 2,863 | 2,951 |
| Provision for income taxes | 240 | 226 | 682 | 685 |
| Net income including noncontrolling interests | 779 | 766 | 2,181 | 2,266 |
| Less: Net income attributable to noncontrolling interests | 28 | 31 | 91 | 97 |
| Net income attributable to Colgate-Palmolive Company | 751 | 735 | 2,090 | 2,169 |
| Earnings per common share, basic | 0.94 | 0.91 | 2.61 | 2.68 |
| Earnings per common share, diluted | 0.94 | 0.91 | 2.61 | 2.67 |

##### Balance Sheet (From the 10-Q · (Unaudited))

| | September 30, 2026 | December 31, 2025 |
|---|---:|---:|
| **Current Assets** | | |
| Cash and cash equivalents | 1,527 | 1,288 |
| Receivables (net of allowances of $90 and $90, respectively) | 1,901 | 1,675 |
| Inventories | 2,182 | 2,032 |
| Other current assets | 747 | 714 |
| Total current assets | 6,357 | 5,709 |
| **Property, plant and equipment:** | | |
| Cost | 11,097 | 10,856 |
| Less: Accumulated depreciation | -6,484 | -6,196 |
| Property, plant and equipment, net | 4,613 | 4,660 |
| Goodwill | 3,080 | 3,122 |
| Other intangible assets, net | 1,472 | 1,536 |
| Deferred income taxes | 222 | 205 |
| Other assets | 998 | 1,098 |
| Total assets | 16,742 | 16,330 |
| **Current Liabilities** | | |
| Debt payable within one-year | 532 | 1,117 |
| Accounts payable | 2,096 | 2,089 |
| Accrued income taxes | 358 | 383 |
| Other accruals | 3,653 | 3,264 |
| Total current liabilities | 6,639 | 6,853 |
| Long-term debt | 7,184 | 6,871 |
| Deferred income taxes | 262 | 181 |
| Other liabilities | 2,017 | 2,060 |
| Total liabilities | 16,102 | 15,965 |
| **Shareholders’ Equity** | | |
| Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued) | 1,466 | 1,466 |
| Additional paid-in capital | 4,474 | 4,322 |
| Retained earnings | 27,415 | 26,595 |
| Accumulated other comprehensive income (loss) | -3,866 | -3,879 |
| Treasury stock, at cost | -29,201 | -28,450 |
| Total Colgate-Palmolive Company shareholders’ equity | 288 | 54 |
| Noncontrolling interests | 352 | 311 |
| Total equity | 640 | 365 |
| Total liabilities and equity | 16,742 | 16,330 |

##### Cash Flow (From the 10-Q · Nine Months Ended — (Unaudited))

| | Nine Months Ended – September 30, – 2026 | Nine Months Ended – September 30, – 2025 |
|---|---:|---:|
| **Operating Activities** | | |
| Net income including noncontrolling interests | 2,181 | 2,266 |
| **Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:** | | |
| Depreciation and amortization | 470 | 457 |
| ERISA litigation matter |  | 65 |
| Restructuring and termination benefits, net of cash | 177 | -15 |
| Stock-based compensation expense | 141 | 127 |
| Deferred income taxes | 54 | 8 |
| **Cash effects of changes in:** | | |
| Receivables | -224 | -180 |
| Inventories | -104 | 9 |
| Accounts payable and other working capital | 254 | 30 |
| Other non-current assets | 48 | 48 |
| Other non-current liabilities | -84 | -70 |
| Net cash provided by (used in) operations | 2,913 | 2,745 |
| **Investing Activities** | | |
| Capital expenditures | -400 | -387 |
| Purchases of marketable securities and investments | -163 | -537 |
| Proceeds from sale of marketable securities and investments | 187 | 508 |
| Payment for acquisition, net of cash acquired |  | -293 |
| Other investing activities | -5 | -5 |
| Net cash provided by (used in) investing activities | -381 | -714 |
| **Financing Activities** | | |
| Short-term borrowing (repayment) less than 90 days, net | 947 | 139 |
| Principal payments of debt | -1,087 | -655 |
| Proceeds from issuance of debt |  | 497 |
| Dividends paid | -1,308 | -1,300 |
| Purchases of treasury shares | -927 | -804 |
| Proceeds from exercise of stock options | 178 | 83 |
| Other financing activities | -75 | 145 |
| Net cash provided by (used in) financing activities | -2,272 | -1,895 |
| Effect of exchange rate changes on Cash and cash equivalents | -21 | 47 |
| Net increase (decrease) in Cash and cash equivalents | 239 | 183 |
| Cash and cash equivalents at beginning of the period | 1,288 | 1,096 |
